000			01980 a2200625 4500
005			20250517121707.0
264		0	_c20170425
008			201704s 0 0 eng d
022			_a1476-5594
024	7		_a10.1038/onc.2016.382 _2doi
040			_aNLM _beng _cNLM
100	1		_aHarrod, A
245	0	0	_aGenomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer. _h[electronic resource]
260			_bOncogene _c04 2017
300			_a2286-2296 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aCRISPR-Cas Systems
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aCyclin-Dependent Kinases _xantagonists & inhibitors
650	0	4	_aEstrogen Antagonists _xpharmacology
650	0	4	_aEstrogen Receptor alpha _xgenetics
650	0	4	_aEstrogens _xpharmacology
650	0	4	_aFemale
650	0	4	_aGene Knock-In Techniques
650	0	4	_aHistones _xmetabolism
650	0	4	_aHumans
650	0	4	_aMCF-7 Cells
650	0	4	_aMutation
650	0	4	_aPhosphorylation
650	0	4	_aSerine _xmetabolism
650	0	4	_aTamoxifen _xanalogs & derivatives
650	0	4	_aCyclin-Dependent Kinase-Activating Kinase
700	1		_aFulton, J
700	1		_aNguyen, V T M
700	1		_aPeriyasamy, M
700	1		_aRamos-Garcia, L
700	1		_aLai, C-F
700	1		_aMetodieva, G
700	1		_ade Giorgio, A
700	1		_aWilliams, R L
700	1		_aSantos, D B
700	1		_aGomez, P J
700	1		_aLin, M-L
700	1		_aMetodiev, M V
700	1		_aStebbing, J
700	1		_aCastellano, L
700	1		_aMagnani, L
700	1		_aCoombes, R C
700	1		_aBuluwela, L
700	1		_aAli, S
773	0		_tOncogene _gvol. 36 _gno. 16 _gp. 2286-2296
856	4	0	_uhttps://doi.org/10.1038/onc.2016.382 _zAvailable from publisher's website
999			_c26522432 _d26522432